|
1
|
Stebbing J and Ellis P: An overview of
drug development for metastatic breast cancer. Br J Nurs. 21 Sup
4:S18–S22. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jia LY, Shanmugam MK, Sethi G and Bishayee
A: Potential role of targeted therapies in the treatment of
triple-negative breast cancer. Anticancer Drugs. 27:147–155. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Saha P and Nanda R: Concepts and targets
in triple-negative breast cancer: Recent results and clinical
implications. Ther Adv Med Oncol. 8:351–359. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tseng LM, Hsu NC, Chen SC, Lu YS, Lin CH,
Chang DY, Li H, Lin YC, Chang HK, Chao TC, et al: Distant
metastasis in triple-negative breast cancer. Neoplasma. 60:290–294.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Micalizzi DS, Farabaugh SM and Ford HL:
Epithelial-mesenchymal transition in cancer: Parallels between
normal development and tumor progression. J Mammary Gland Biol
Neoplasia. 15:117–134. 2010. View Article : Google Scholar
|
|
6
|
Creighton CJ, Gibbons DL and Kurie JM: The
role of epithelial-mesenchymal transition programming in invasion
and metastasis: A clinical perspective. Cancer Manag Res.
5:187–195. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kotiyal S and Bhattacharya S: Epithelial
mesenchymal transition and vascular mimicry in breast cancer stem
cells. Crit Rev Eukaryot Gene Expr. 25:269–280. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang J, Li H and Ren G:
Epithelial-mesenchymal transition and drug resistance in breast
cancer (Review). Int J Oncol. 47:840–848. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kenneth NS and Duckett CS: IAP proteins:
Regulators of cell migration and development. Curr Opin Cell Biol.
24:871–875. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Argon A, Nart D, Oruç N, Coker A and
Ozütemiz O: The prognostic significance of clinicopathological
features and apoptosis inhibitor proteins in pancreas ductal
adenocarcinoma. Acta Gastroenterol Belg. 77:229–234.
2014.PubMed/NCBI
|
|
11
|
Jayakumar J and Anishetty S: Molecular
dynamics simulations of inhibitor of apoptosis proteins and
identification of potential small molecule inhibitors. Bioorg Med
Chem Lett. 24:2098–2104. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li CJ, Cong Y, Liu XZ, Zhou X, Shi X, Wu
SJ, Zhou GX and Lu M: Research progress on the livin gene and
osteosarcomas. Asian Pac J Cancer Prev. 15:8577–8579. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ge Y, Cao X, Wang D, Sun W, Sun H, Han B,
Cui J and Liu B: Overexpression of Livin promotes migration and
invasion of colorectal cancer cells by induction of
epithelial-mesenchymal transition via NF-κB activation. Onco
Targets Ther. 9:1011–1021. 2016.PubMed/NCBI
|
|
14
|
Ryu HS, Chung JH, Lee K, Shin E, Jing J,
Choe G, Kim H, Xu X, Lee HE, Kim DG, et al: Overexpression of
epithelial-mesenchymal transition-related markers according to cell
dedifferentiation: Clinical implications as an independent
predictor of poor prognosis in cholangiocarcinoma. Hum Pathol.
43:2360–2370. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ryu HS, Park DJ, Kim HH, Kim WH and Lee
HS: Combination of epithelial-mesenchymal transition and cancer
stem cell-like phenotypes has independent prognostic value in
gastric cancer. Hum Pathol. 43:520–528. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen HH, Zhou XL, Shi YL and Yang J: Roles
of p38 MAPK and JNK in TGF-β1-induced human alveolar epithelial to
mesenchymal transition. Arch Med Res. 44:93–98. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang B, Yang Y, Shi X, Liao W, Chen M,
Cheng AS, Yan H, Fang C, Zhang S, Xu G, et al: Proton pump
inhibitor pantoprazole abrogates adriamycin-resistant gastric
cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin
signaling and epithelial-mesenchymal transition. Cancer Lett.
356:704–712. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chung CY, Park YL, Kim N, Park HC, Park
HB, Myung DS, Kim JS, Cho SB, Lee WS and Joo YE: Expression and
prognostic significance of Livin in gastric cancer. Oncol Rep.
30:2520–2528. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Li Y, Zhou B, Zhang WY, Guan JT,
Wang R, Yang L, Xia QJ, Zhou ZG and Sun XF: Expression of the
apoptosis inhibitor livin in colorectal adenoma-carcinoma sequence:
Correlations with pathology and outcome. Tumour Biol.
35:11791–11798. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gu J, Ren L, Wang X, Qu C and Zhang Y:
Expression of livin, survivin and caspase-3 in prostatic cancer and
their clinical significance. Int J Clin Exp Pathol. 8:14034–14039.
2015.PubMed/NCBI
|
|
21
|
Li J, Chen P, Li XQ, Bao QL, Dai CH and Ge
LP: Elevated levels of survivin and livin mRNA in bronchial
aspirates as markers to support the diagnosis of lung cancer. Int J
Cancer. 132:1098–1104. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Campbell K and Casanova J: A common
framework for EMT and collective cell migration. Development.
143:4291–4300. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu X and Fan D: The
epithelial-mesenchymal transition and cancer stem cells: Functional
and mechanistic links. Curr Pharm Des. 21:1279–1291. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee JY and Kong G: Roles and epigenetic
regulation of epithelial-mesenchymal transition and its
transcription factors in cancer initiation and progression. Cell
Mol Life Sci. 73:4643–4660. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kawata H, Kamiakito T, Omoto Y, Miyazaki
C, Hozumi Y and Tanaka A: RhoC upregulation is correlated with
reduced E-cadherin in human breast cancer specimens after
chemotherapy and in human breast cancer MCF-7 cells. Horm Cancer.
5:414–423. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bastos LG, de Marcondes PG,
de-Freitas-Junior JC, Leve F, Mencalha AL, de Souza WF, de Araujo
WM, Tanaka MN, Abdelhay ES and Morgado-Díaz JA: Progeny from
irradiated colorectal cancer cells acquire an EMT-like phenotype
and activate Wnt/β-catenin pathway. J Cell Biochem. 115:2175–2187.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Muqbil I, Wu J, Aboukameel A, Mohammad RM
and Azmi AS: Snail nuclear transport: The gateways regulating
epithelial-to-mesenchymal transition? Semin Cancer Biol. 27:39–45.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Y, Shi J, Chai K, Ying X and Zhou BP:
The role of Snail in EMT and tumorigenesis. Curr Cancer Drug
Targets. 13:963–972. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guo Q, Ning F, Fang R, Wang HS, Zhang G,
Quan MY, Cai SH and Du J: Endogenous Nodal promotes melanoma
undergoing epithelial-mesenchymal transition via Snail and Slug in
vitro and in vivo. Am J Cancer Res. 5:2098–2112. 2015.PubMed/NCBI
|
|
30
|
Bouris P, Skandalis SS, Piperigkou Z,
Afratis N, Karamanou K, Aletras AJ, Moustakas A, Theocharis AD and
Karamanos NK: Estrogen receptor alpha mediates epithelial to
mesenchymal transition, expression of specific matrix effectors and
functional properties of breast cancer cells. Matrix Biol.
43:42–60. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tao T, Shi Y, Han D, Luan W, Qian J, Zhang
J, Wang Y and You Y: Chinese Glioma Cooperative Group (CGCG): TPM3,
a strong prognosis predictor, is involved in malignant progression
through MMP family members and EMT-like activators in gliomas.
Tumour Biol. 35:9053–9059. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liang Z, Wu R, Xie W, Geng H, Zhao L, Xie
C, Wu J, Geng S, Li X, Zhu M, et al: Curcumin suppresses MAPK
pathways to reverse tobacco smoke-induced gastric
epithelial-mesenchymal transition in mice. Phytother Res.
29:1665–1671. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ou JM, Ye B, Qiu MK, Dai YX, Dong Q, Shen
J, Dong P, Wang XF, Liu YB, Quan ZW, et al: Knockdown of Livin
inhibits growth and invasion of gastric cancer cells through
blockade of the MAPK pathway in vitro and in vivo.
Int J Oncol. 44:276–284. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bikkavilli RK, Feigin ME and Malbon CC:
p38 mitogen-activated protein kinase regulates canonical
Wnt-beta-catenin signaling by inactivation of GSK3beta. J Cell Sci.
121:3598–3607. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liang Y, Jing Z, Deng H, Li Z, Zhuang Z,
Wang S and Wang Y: Soluble epoxide hydrolase inhibition ameliorates
proteinuria-induced epithelial-mesenchymal transition by regulating
the PI3K-Akt-GSK-3β signaling pathway. Biochem Biophys Res Commun.
463:70–75. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li F, Yin X, Luo X, Li HY, Su X, Wang XY,
Chen L, Zheng K and Ren GS: Livin promotes progression of breast
cancer through induction of epithelial-mesenchymal transition and
activation of AKT signaling. Cell Signal. 25:1413–1422. 2013.
View Article : Google Scholar : PubMed/NCBI
|
